Copies of Biological Medicines: Similar But Not the Same?

por Kurki, Pekka
Publicado 2023

Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective

por Kurki, Pekka, Barry, Sean, Bourges, Ingrid, Tsantili, Panagiota, Wolff-Holz, Elena
Publicado 2021

Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience

por Kurki, Pekka, Kang, Hye-Na, Ekman, Niklas, Knezevic, Ivana, Weise, Martina, Wolff-Holz, Elena
Publicado 2022

Medication safety risks to be managed in national implementation of automatic substitution of biological medicines: a qualitative study

por Tolonen, Hanna M, Airaksinen, Marja SA, Ruokoniemi, Päivi, Hämeen-Anttila, Katri, Shermock, Kenneth M, Kurki, Pekka
Publicado 2019

Is There Any Research Evidence Beyond Surveys and Opinion Polls on Automatic Substitution of Biological Medicines? A Systematic Review

por Tolonen, Hanna M., Falck, Jenni, Kurki, Pekka, Ruokoniemi, Päivi, Hämeen-Anttila, Katri, Shermock, Kenneth M., Airaksinen, Marja
Publicado 2021